Galera Therapeutics Inc (GRTX)

Currency in USD
0.023
-0.001(-4.20%)
Closed·
GRTX Scorecard
Full Analysis
Suffers from weak gross profit margins
Earnings results expected in 8 days
GRTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0230.025
52 wk Range
0.0210.092
Key Statistics
Prev. Close
0.024
Open
0.024
Day's Range
0.023-0.025
52 wk Range
0.021-0.092
Volume
8.22K
Average Volume (3m)
55.1K
1-Year Change
-65.07%
Book Value / Share
-1.95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Galera Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Galera Therapeutics Inc Company Profile

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy that is in Phase 2a clinical trial. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.

Compare GRTX to Peers and Sector

Metrics to compare
GRTX
Peers
Sector
Relationship
P/E Ratio
−0.1x−4.5x−0.5x
PEG Ratio
0.000.010.00
Price/Book
0.0x2.7x2.6x
Price / LTM Sales
-150.6x3.3x
Upside (Analyst Target)
-187.1%43.4%
Fair Value Upside
Unlock2.9%7.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GRTX Income Statement

FAQ

What Stock Exchange Does Galera Trade On?

Galera is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Galera?

The stock symbol for Galera is "GRTX."

What Is the Galera Market Cap?

As of today, Galera market cap is 1.74M.

What Is Galera's Earnings Per Share (TTM)?

The Galera EPS (TTM) is -0.25.

When Is the Next Galera Earnings Date?

Galera will release its next earnings report on 17 Aug 2025.

From a Technical Analysis Perspective, Is GRTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Galera Stock Split?

Galera has split 0 times.

How Many Employees Does Galera Have?

Galera has 3 employees.

What is the current trading status of Galera (GRTX)?

As of 10 Aug 2025, Galera (GRTX) is trading at a price of 0.02, with a previous close of 0.02. The stock has fluctuated within a day range of 0.02 to 0.03, while its 52-week range spans from 0.02 to 0.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.